Edwards Lifesciences (EW)

87.38 -0.02  -0.02%  May 29, 11:06AM Go Pro
Watch this stock
View Full Chart EW Price Chart

Key Stats

Market Cap 10.05B
Revenue Growth 13.52%
Profit Margin 14.18%
Earnings Yield 2.29%
Dividend Yield 0.00%
Earnings Per Share TTM 2.00
PE Ratio 43.69
Price / Sales Ratio 5.796
52 Week High 91.50
52 Week Low 61.59
Beta 0.538
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 28 6 Rallying Healthcare Stocks With Strong Receivable Trends. $BMRN $ERT $EW $KNSY $TECH $YDNT http://stks.co/40JA by abubnic
May 28 $EW - Trade Signal New - BTO @ 87.40-Limit w/77.80-Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/dxtl9lb by TraderFoxxx
May 26 $EW trying to B/O here. worth stalking. by 1nvestor
May 25 $EW Insider Sale: $1.3M of stock sold by Ingram Robert Alexander on May 25, 2012 http://stks.co/3zhq by MarketBrief
May 22 4 Stocks Proving That Regulation Matters Fool
May 20 Top 5 Healthcare by 14 period RSI: $PFE $EW $BIIB $ABT $LLY (S&P 500) $VRTX $ARNA $AMLN $AKRX $SEM (non S&P 500) by TheEquitiesRoom
May 20 RT @harmongreg Top Trade Ideas for the Week of May 21, 2012: The Rest http://stks.co/3uUK $ATHN $CERN $EW $HFC $HOMB by LPLongo
May 20 Top Trade Ideas for the Week of May 21, 2012: The Rest http://stks.co/3uTz $ATHN $CERN $EW $HFC $HOMB by harmongreg
May 20 Insider action http://stks.co/3uPJ with a smart move by $EW insider Larry Wood. (I am short, a "to fade" trade). by 1nvestor
May 19 Noteworthy Insider Buys Last Week In 2 Beaten Down Biotechs, With 4 Other Buys And Se...
May 18 Canaccord Genuity Reiterates a' Buy' on Edwards Lifesciences (EW); SOURCE XT Bodes We...
May 17 Forbes Earnings Preview: Medtronic
May 17 Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient Outcomes ...

Profile

Exchange: NYSE       Sector: Healthcare       Industry: Medical Appliances & Equipment

Edwards Lifesciences Corporation, incorporated on September 10, 1999, is a global player in products and technologies designed to treat advanced cardiovascular disease. The Company is focused specifically on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease are categorized into four areas: Heart Valve Therapy, Critical Care, Cardiac Surgery Systems and Vascular. The company distributes its products through direct sales force and independent distributors. The company is headquartered in Irvine, California. Edwards Lifesciences Corporation operates independently of Baxter International Inc., as of March 31, 2000.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Edwards Lifesciences is down 0.79% over the last year vs S&P 500 Total Return up 1.18%, Boston Scientific Corporation down 15.55%, and St. Jude Medical down 19.78%.

  • EW Total Returns
  • ^SPXTR Total Returns
  • BSX Total Returns
  • STJ Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring EW

Did Edwards Lifesciences make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

EW Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
EW 87.38 -0.02 -0.02% 10.05B
EVY 14.85 +0.08 +0.51%
EVX 46.43 +0.33 +0.72%
EVV 16.19 +0.06 +0.37%
EVT 15.84 +0.13 +0.83%
EVR 25.09 +0.42 +1.70% 711.48M
EVOL 7.06 -0.01 -0.14% 78.48M
ETFC 8.96 +0.28 +3.23% 2.480B
ETF 18.08 +0.24 +1.35%
ETE 37.62 -0.05 -0.13% 8.399B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close